The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cardiovascular devices market was valued at US$ 51.34 Billion in 2021.
We expect the global cardiovascular devices market to exhibit a CAGR of 6.70% during 2022-2027.
The sudden outbreak of the COVID-19 pandemic had led to postponement of elective heart treatments and procedures to reduce the risk of the coronavirus infection upon hospital visits or interaction with healthcare professionals and medical equipment, thereby negatively impacting the global market for cardiovascular devices.
The rising demand for cardiovascular devices to manage life-threatening conditions effectively, minimize patient discomfort, and enhance the quality of life, is primarily driving the cardiovascular devices market.
Based on the device type, the global cardiovascular devices market can be segmented into diagnostic and monitoring devices and therapeutic and surgical devices. Currently, therapeutic and surgical devices hold the majority of the total market share.
Based on the application, the global cardiovascular devices market has been divided into Coronary Artery Disease (CAD), cardiac arrhythmia, heart failure, and others. Among these, Coronary Artery Disease (CAD) currently exhibits a clear dominance in the market.
Based on the end user, the global cardiovascular devices market can be categorized into hospitals, specialty clinics, and others. Currently, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global cardiovascular devices market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG), and Terumo Cardiovascular Systems Corporation (Terumo Corporation).
Electrophoresis Equipment Market by Product Type (Gel Electrophoresis Systems, Capillary Electrophoresis Systems, Electrophoresis Accessories), Type (Vertical Electrophoresis, Horizontal Electrophoresis), End User (Hospitals and Diagnostics Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Others), and Region 2023-2028
Dental Handpieces Market by Product (Air-Driven Handpieces, Electric Handpieces, Hybrid Air-Electric Handpieces), Speed (High- Speed, Low-Speed), End-User (Dental Clinics, Hospitals, and Others), and Region 2023-2028
Inferior Vena Cava (IVC) Filter Market by Product (Retrievable IVC Filter, Permanent IVC Filter), Material (Non-Ferromagnetic Materials, Ferromagnetic Materials), Application (Treatment Venous Thromboembolism (VTE), Prevent Pulmonary Embolism (PE), and Others), End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at